The primary preventional and secondary interventative effects of acetyl-L-carnitine on diabetic neuropathy in the BB/W-rat
At the start of treatment, the average age was 57.5 years, the mean BMI was 34.7 kg/m2, and 61% had type 2 diabetes
Its active component (gymnemic acid) has been found to block sugar receptors on taste buds - reducing the sweetness of sugar - which in turn can help in reducing sugar cravings
It modulates GABA and serotonin activity in the brain, producing a calm, anxiolytic effect that quiets the racing thoughts and evening anxiety that prevent millions of people from falling asleep
Koizumi A, Nozaki J, Ohura T, Kayo T, Wada Y, Nezu J, Ohashi R, Tamai I, Shoji Y, Takada G, Kibira S, Matsuishi T, Tsuji A: Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency
As generic medicines expand access, pharmacovigilance must evolve alongside them